Altogether the above data showed that administration of EPO through both systemic and local routes could effectively correct cisplatin‐induced anemia; however, only EPO given through renal local injection could efficiently protect the kidney from severe cisplatin injury. The gene discussed is EPO; the disease is anemia (phenotype).